Form 4: Tyra Biosciences Director Nina Kjellson Sells Shares in Multiple Transactions

Director Nina Kjellson of Tyra Biosciences sold shares indirectly through related investment entities in multiple transactions between January 16th and January 21st, 2025.

Summary

• Nina Kjellson, a director at Tyra Biosciences, indirectly sold a total of 24,981 shares of common stock through related investment entities.
• The sales occurred over several days, specifically on January 16th, 17th, and 21st of 2025.
• The shares were sold at weighted average prices ranging from $16.287 to $16.4001 per share.
• The transactions were executed through Canaan XI L.P. and 2020+ Co-Investment L.P. Series 7, where Kjellson is a partner.
• Following these transactions, Kjellson still indirectly holds a substantial number of shares through these entities.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction, which is neither particularly positive nor negative for the company's outlook.

Risks

• The sales by a director could be perceived negatively by the market, potentially impacting the stock price.
• The indirect nature of the sales through investment partnerships adds complexity to the ownership structure.

Industry Context

Insider sales are a common occurrence in publicly traded companies, and this transaction is within the normal course of business for a director managing their personal investments.

Comparison to Industry Standards

• It is common for directors of publicly traded companies to sell shares, often for personal financial planning or diversification.
• The volume of shares sold by Nina Kjellson is not unusual for a director with significant holdings.
• The weighted average prices achieved are within the typical range for market transactions.

Stakeholder Impact

• The sales may cause minor fluctuations in the stock price, but the overall impact on stakeholders is likely to be minimal.

Key Dates

Keywords

Tyra Biosciences, Nina Kjellson, stock sales, insider trading, Canaan XI L.P., 2020+ Co-Investment L.P., director, share transactions